 SAN DIEGO, Feb. 07, 2022 GLOBE NEWSWIRE -- Prometheus Biosciences, Inc. Nasdaq: RXDX, a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, today announced that Mark McKenna, Chairman and CEO, will conduct a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022 at 3:40 PM ET. 